Search
Close this search box.

Day: December 15, 2021

African Leaders Call for More Investment in Healthcare

African leaders have called on governments across the continent to invest more in healthcare to fight the coronavirus and future pandemics. The appeal came as the Africa Centers for Disease Control and Prevention and the African Union this week held the first Conference on Public Health in Africa. Addressing the virtual meeting of African health workers and experts, Rwandan President

Read More

Stay Calm, Don’t Panic, Says South African Doctor

The head of the South African Medical Association says there is a major difference between the delta and omicron variants of the coronavirus and warns politicians against hyping the threat from the new strain. Dr. Angelique Coetzee criticized Tuesday what she described as the “over-reaction” to the heavily mutated omicron variant by some European governments and cited Britain’s Boris Johnson,

Read More

Charting the Future of China’s Infrastructure Projects in Africa After a Decade of Lending

China is financing the construction of four coal-fired power plants in southern Africa, despite its climate pledge in September to quit supporting such infrastructure overseas. But the new facilities taking shape in South Africa and Zimbabwe are just a few of Beijing’s massive investments in airports, railway lines and other national infrastructure on the African continent. Many countries have been

Read More

Adagio Therapeutics annonce une réduction de l’activité neutralisante in vitro de l’ADG20 contre le variant Omicron du virus SARS-CoV-2

Les données in vitro précédemment rapportées démontrant que les mutations Omicron individuelles n’étaient pas associées à l’échappement de l’ADG20 ne se traduisent pas par des essais Omicron sur des souches authentiques et des pseudovirus WALTHAM, Mass., 14 déc. 2021 (GLOBE NEWSWIRE) — Adagio Therapeutics, Inc. (Nasdaq : ADGI), une société biopharmaceutique au stade clinique axée sur […]

Read More

Adagio Therapeutics Relata Redução na Atividade Neutralizante In Vitro do ADG20 Contra a Variante Omicron SARS-CoV-2

Dados in vitro relatados anteriormente que demonstram que as mutações individuais do Omicron não estavam associadas à fuga de ADG20 não se confirmam nos ensaios autênticos de Omicron e de Pseudovírus WALTHAM, Mass., Dec. 14, 2021 (GLOBE NEWSWIRE) — A Adagio Therapeutics, Inc., (Nasdaq: ADGI) uma empresa biofarmacêutica de estágio clínico focada na descoberta, desenvolvimento […]

Read More